Ask AI

Why B7-H3 Is a Clinically Relevant Target in ES-SCLC

Downloadable slides to learn more about why B7-H3 is a clinically relevant target in ES-SCLC, and gain more insight into the biology and promising investigational agents such as ifinatamab deruxtecan (I-DXd) targeting B7-H3 in ES-SCLC.

Overview of B7 H3 in ES-SCLC

Activity Information

Released: October 27, 2026